Join the Docetaxel group to help and get support from people like you.
Docetaxel News
FDA Medwatch Alert: Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Docetaxel Injection, USP Due to Potential Presence of Particulate Matter
SCHAUMBURG, IL – May 28, 2024 – Sagent Pharmaceuticals today announced the voluntary nationwide recall of two lots of Docetaxel Injection, USP (80 mg per 8 mL multi-dose vials and 160 mg per 16 mL mul...
Teikoku Pharma USA, Inc. Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
San Jose, Calif. - December 28, 2015 - Teikoku Pharma USA (TPU) announced today that the U.S. Food and Drug Administration ("FDA") has approved Docetaxel Injection, Non-Alcohol Formula ("Docetaxel...
FDA Medwatch Alert: Docetaxel: Drug Safety Communication - May Cause Symptoms of Alcohol Intoxication
ISSUE: FDA is warning that the intravenous chemotherapy drug docetaxel contains ethanol, also known as alcohol, which may cause patients to experience intoxication or feel drunk during and after...
Sun Pharma Announces US FDA Approval for Docefrez (docetaxel) for Injection
Mumbai, May 4, 2011: Sun Pharmaceutical Industries Ltd. announced that US FDA has granted its subsidiary an approval for its New Drug Application (NDA) for Docefrez (docetaxel) for Injection, 20...
FDA Approves New Taxotere (docetaxel) Injection Concentrate Formulation
BRIDGEWATER, N.J., Aug. 5 /PRNewswire/ – Sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved a new one-vial formulation of its chemotherapeutic agent...
Further information
Related condition support groups
Prostate Cancer, Breast Cancer, Gastric Cancer, Breast Cancer, Metastatic, Non-Small Cell Lung Cancer